Latest stories on MDWD
MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares
GlobeNewswire26 · bearishgeneral
MediWound Announces $17.25 Million Share Offering After Full Option Exercise
TipRanks24 · bearishgeneral
MediWound announces $15M public offering of ordinary shares
Seeking Alpha26 · bearishgeneral
MediWound announces $15M bought deal offering of ordinary shares
The Fly26 · bearishgeneral
MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
GlobeNewswire28 · bearishgeneral
MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
StockTitan26 · bearishgeneral
MediWound to Report Third Quarter 2026 Financial Results
GlobeNewswire50 · neutralearnings
TD Cowen reiterates MediWound stock rating ahead of trial data
Investing.com Analyst Ratings56 · neutralanalyst
MediWound awarded additional $3.3M from DOW to advance NexoBrid
The Fly63 · neutralgeneral
MediWound price target raised to $27 from $22 at Alliance Global
The Fly61 · neutralanalyst
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
GlobeNewswire67 · bullishproduct/pr
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
StockTitan63 · neutralproduct/pr
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq: MDWD)
Business Insider58 · neutralproduct/pr
MediWound (MDWD) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
MediWound backs FY26 revenue view $24M-$26M, consensus $24.13M
The Fly56 · neutralgeneral
MediWound reports Q2 EPS ($1.36), consensus (77c)
The Fly28 · bearishearnings
MediWound price target lowered to $30 from $32 at Oppenheimer
The Fly42 · neutralanalyst
MediWound reaffirms $24M-$26M 2026 revenue guidance as EscharEx Phase III milestones near by Q1 2027
Seeking Alpha58 · neutralproduct/pr
MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
MediWound Q2 2026 Results Highlight EscharEx Trial Progress and New NexoBrid BARDA Agreement
TipRanks63 · neutralproduct/pr
MediWound beats top-line and bottom-line estimates; reaffirms FY26 outlook
Seeking Alpha63 · neutralearnings
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire56 · neutralearnings